Journal
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
Volume 94, Issue 3, Pages 360-370Publisher
ELSEVIER SCIENCE INC
DOI: 10.1016/j.critrevonc.2015.02.003
Keywords
Prostate cancer; High-dose rate brachytherapy; Salvage brachytherapy; HDR-BT; Brachytherapy boost; Radiobiology
Categories
Ask authors/readers for more resources
The intrinsic physical and radiobiological characteristics of High Dose Rate Brachytherapy (HDR-BT) are well suited to the treatment of prostate cancer. HDR-BT was initially used as a boost to external beam brachytherapy, but has subsequently been employed as the sole treatment, which is termed HDR monotherapy. This review summarizes the clinical outcomes and toxicity results of the principal studies and discusses the radiobiological basis supporting its use. (C) 2015 Elsevier Ireland Ltd. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available